{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:30:30Z","timestamp":1698780630412},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1157\/13116170","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T11:33:59Z","timestamp":1210332839000},"page":"201-205","source":"Crossref","is-referenced-by-count":10,"title":["Prevalencia y caracter\u00edsticas cl\u00ednicas de la microalbuminuria en la poblaci\u00f3n espa\u00f1ola con hipertensi\u00f3n arterial"],"prefix":"10.1016","volume":"130","author":[{"given":"Alejandro","family":"de la Sierra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Isabel Egocheaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Teresa Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13116170_bb0005","doi-asserted-by":"crossref","unstructured":"Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.J Hypertens. 2003; 21:1011-53.","DOI":"10.1097\/00004872-200306000-00001"},{"key":"10.1157\/13116170_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1157\/13076402","article-title":"Gu\u00eda sobre el diagn\u00f3stico y tratamiento de la hipertensi\u00f3n arterial en Espa\u00f1a 2005","volume":"125","author":"Mar\u00edn","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13116170_bb0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.106.177321","volume":"114","author":"Brosius","year":"2006","journal-title":"Circulation"},{"key":"10.1157\/13116170_bb0020","first-page":"1430","article-title":"Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus","volume":"1","author":"Viberti","year":"1987","journal-title":"Lancet"},{"key":"10.1157\/13116170_bb0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","article-title":"Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes","volume":"310","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1157\/13116170_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(94)91047-2","article-title":"Microalbuminuria and endotelial dysfunction in essential hypertension","volume":"344","author":"Pedrinelli","year":"1994","journal-title":"Lancet"},{"key":"10.1157\/13116170_bb0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.ATV.19.3.617","article-title":"Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality,especially among hypertensive subjects: fiveyear follow-up of the Hoorn Study","volume":"19","author":"Jager","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1157\/13116170_bb0040","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.HYP.35.4.898","article-title":"Arterial hypertension,microalbuminuria, and risk of ischemic heart disease","volume":"35","author":"Jensen","year":"2000","journal-title":"Hypertension"},{"key":"10.1157\/13116170_bb0045","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/01.CIR.0000103667.27493.32","article-title":"Microalbuminuria and all-cause mortality in treated hypertensive individuals. Does sex matter? The Nord-Tr\u00f8ndelag Health Study (HUNT), Norway","volume":"108","author":"Romundstad","year":"2003","journal-title":"Circulation"},{"key":"10.1157\/13116170_bb0050","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-139-11-200312020-00008","article-title":"Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study","volume":"139","author":"Wachtell","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1157\/13116170_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2002.33906","article-title":"Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men","volume":"40","author":"Dell\u2019Omo","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1157\/13116170_bb0060","first-page":"287","article-title":"Microalbuminuria in essential hypertension: clinical and biochemical profile","volume":"57","author":"De la Sierra","year":"2000","journal-title":"Br J Biomed Sci"},{"key":"10.1157\/13116170_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0895-7061(97)00498-6","article-title":"Microalbuminuria is an early marker of target organ damage in essential hypertension","volume":"11","author":"Pontremoli","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1157\/13116170_bb0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00004872-200207000-00018","article-title":"Microalbuminuria identifies overall cardiovascular risk in essential hypertension:an artificial neural network-based approach","volume":"20","author":"Leoncini","year":"2002","journal-title":"J Hypertens"},{"key":"10.1157\/13116170_bb0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00004872-200203000-00015","article-title":"Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study","volume":"20","author":"Wachtell","year":"2002","journal-title":"J Hypertens"},{"key":"10.1157\/13116170_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004872-200501000-00028","article-title":"Microalbuminuria, renal function and development of sustained hypertension:a longitudinal study in the early stage of hypertension","volume":"23","author":"Palatini","year":"2005","journal-title":"J Hypertens"},{"key":"10.1157\/13116170_bb0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0895-7061(95)00391-6","article-title":"Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study)","volume":"9","author":"Palatini","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1157\/13116170_bb0090","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.30.5.1135","article-title":"Prevalence and clinical correlates of microalbuminuria in essential hypertension.The MAGIC Study","volume":"30","author":"Pontremoli","year":"1997","journal-title":"Hypertension"},{"key":"10.1157\/13116170_bb0095","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/00004872-199816090-00014","article-title":"Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension","volume":"16","author":"Bigazzi","year":"1998","journal-title":"J Hypertens"},{"key":"10.1157\/13116170_bb0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00004872-199408000-00013","article-title":"Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability","volume":"12","author":"Redon","year":"1994","journal-title":"J Hypertens"},{"key":"10.1157\/13116170_bb0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0025-7753(01)71908-2","article-title":"Prevalencia de microalbuminuria en la poblaci\u00f3n general de un \u00e1rea mediterr\u00e1nea espa\u00f1ola y su asociaci\u00f3n con otros factores de riesgo cardiovascular","volume":"116","author":"Bonet","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13116170_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4321\/S1137-66272004000100004","article-title":"Prevalencia de microalbuminuria en una poblaci\u00f3n hipertensa del norte de Navarra y su relaci\u00f3n con otros factores de riesgo cardiovascular","volume":"27","author":"Aguirre","year":"2004","journal-title":"An Sist Sanit Navar"},{"key":"10.1157\/13116170_bb0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2796.2003.01280.x","article-title":"Microalbuminuria and oxidative stress in essential hypertension","volume":"255","author":"Giner","year":"2004","journal-title":"J Intern Med"},{"key":"10.1157\/13116170_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1157\/13095811","article-title":"Microalbuminuria en pacientes diab\u00e9ticos y en pacientes con hipertensi\u00f3n arterial: estudio de una cohorte de 979 pacientes","volume":"127","author":"Robles","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13116170_bb0125","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection,evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002; 106:3143-421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1157\/13116170_bb0130","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00004872-199607000-00016","article-title":"Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension","volume":"14","author":"Cerasola","year":"1996","journal-title":"J Hypertens"},{"key":"10.1157\/13116170_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00126097-200110000-00004","article-title":"Association of urinary albumin concentration with casual and ambulatory blood pressure: a similar relationship in normotensive and hypertensive subjects","volume":"6","author":"Gerber","year":"2001","journal-title":"Blood Press Monit"},{"key":"10.1157\/13116170_bb0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.mnh.0000168935.95527.0a","article-title":"Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression?","volume":"14","author":"Redon","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577530871399X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577530871399X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T02:34:35Z","timestamp":1557542075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577530871399X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S002577530871399X"],"URL":"https:\/\/doi.org\/10.1157\/13116170","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}